RecruitingPhase 3NCT07223944
Metabolic
Gaucher disease type 3
5
studies recruiting now
as of 7 Sept 2026
42
studies registered in total
as of 7 Sept 2026
10
countries with a recruiting site
as of 7 Sept 2026
3 Nov 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT05586243
MAGNETIC RESONANCE SPECTROSCOPY BIOMARKERS IN TYPE 3 GAUCHER DISEASE (GD3)
RecruitingNCT05619900
Registry of Patients Diagnosed With Lysosomal Storage Diseases
RecruitingPhase 1NCT04532047
PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
RecruitingNCT03240653
Gaucherite - A Study to Stratify Gaucher Disease
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Gaucher disease type 3 studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Gaucher disease type 3 study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Gaucher disease type 3
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations, and the gene involved (GBA1).
Treatments being studied
2 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Venglustat
Phase 3Imiglucerase (Cerezyme)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).